Literature DB >> 1831220

Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver.

S Seki1, T Abo, T Ohteki, K Sugiura, K Kumagai.   

Abstract

Autoimmune MRL-lpr/lpr (lpr) mice develop severe lymphadenopathy, characterized by the accumulation of alpha beta-T cells with CD4-8- double negative (DN) phenotype, at the onset of disease. We previously demonstrated that the liver is a major site for the proliferation of such DN alpha beta-T cells. Herein, we further demonstrate that a large proportion of alpha beta-T cells in the liver and other organs, except the thymus, of lpr mice have unique properties, such as DN phenotype, relatively dull TCR intensity, a preponderance of V beta 8+ cells, and Pgp-1 expression. Interestingly, alpha beta-T cells in the liver of normal mice were found to consist of T cells with intermediate intensity of TCR (i.e., brighter than thymic dull TCR and lower than thymic bright TCR) as well as with bright intensity of TCR in the immunofluorescence test. These hepatic alpha beta-T cells with intermediate TCR in normal mice were found to have properties similar to those of alpha beta-T cells in lpr mice. These results suggest that abnormal alpha beta-T cells in lpr mice are a counterpart of normal T cells in the liver. An abnormal expansion of such T cells in the liver might be fundamental to the pathogenesis involved in these autoimmune mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831220

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Quick recovery in the generation of self-reactive CD4low natural killer (NK) T cells by an alternative intrathymic pathway when restored from acute thymic atrophy.

Authors:  S Maruyama; A Tsukahara; S Suzuki; T Tada; M Minagawa; H Watanabe; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

2.  Extrathymic derivation of gut lymphocytes in parabiotic mice.

Authors:  S Sugahara; T Shimizu; Y Yoshida; T Aiba; S Yamagiwa; H Asakura; T Abo
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

3.  Lymphotoxin activates hepatic T cells and simultaneously induces profound thymic atrophy.

Authors:  A Kusumi; T Abo; T Masuda; K Sugiura; S Seki; T Ohteki; R Okuyama; K Kumagai
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

Review 4.  Biology of autoreactive extrathymic T cells and B-1 cells of the innate immune system.

Authors:  Toru Abo; Chikako Tomiyama; Hisami Watanabe
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

5.  Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease.

Authors:  B Marshall; C Leelayuwat; L J Abraham; M Pinelli; R L Dawkins
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma.

Authors:  Gordon K Lam; Hua-Xin Liao; Yan Xue; S Munir Alam; Richard M Scearce; Russel E Kaufman; Gregory D Sempowski; Barton F Haynes
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates.

Authors:  N Musha; Y Yoshida; S Sugahara; S Yamagiwa; T Koya; H Watanabe; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 8.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

9.  Germline transcription and expression of Tcrb-V8 genes in peripheral mouse lymphoid tissues.

Authors:  H C O'Neill; C J Jolly
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Identification of CD4- CD8- alpha beta T cells in the subarachnoid space of rats with experimental autoimmune encephalomyelitis. A possible route by which effector cells invade the lesions.

Authors:  M Tsuchida; H Hanawa; H Hirahara; H Watanabe; Y Matsumoto; H Sekikawa; T Abo
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.